OVERVIEW

sHTG Disorders in Clinical Practice: Using Familial Chylomicronemia Syndrome to Highlight Diagnosis and Management is organized by Cardiovascular Institute (CVI) of Philadelphia.

Statement of Need:
Severe hypertriglyceridemia (sHTG), defined as triglycerides ?500 mg/dL, poses significant clinical challenges including recurrent acute pancreatitis. While often driven by secondary factors like obesity, diabetes, or medications, Familial Chylomicronemia Syndrome (FCS) represents a rare monogenic form with triglycerides typically >880 mg/dL. Many clinicians feel underprepared to manage sHTG effectively, with low awareness of nutritional strategies, emerging therapies, and indications for genetic testing. This program uses FCS as an illustrative framework to enhance understanding of the full spectrum of sHTG disorders through expert presentations, patient perspectives, and interactive discussion.

Learning Objectives:

Describe the range of triglyceride disorders and recognize their clinical importance.
Differentiate Familial Chylomicronemia Syndrome from other causes of severe hypertriglyceridemia using clinical and genetic information.
Apply evidence-based nutrition and lifestyle strategies for managing elevated triglycerides.
Summarize current and emerging pharmacologic treatments for triglyceride disorders.
Incorporate patient perspectives and collaborate with multidisciplinary teams to improve care for patients with severe triglyceride disorders.

ACCREDITATION & CREDITS

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine (PIM) and the Cardiovascular Institute of Philadelphia. In support of improving patient care, Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA: PIM designates this live activity for a maximum of 2.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAPA: PIM designates this activity for 2.50 AAPA Category 1 CME credits. Physician Associates should claim only the credit commensurate with the extent of their participation in the activity.

ANCC: PIM designates this activity for 2.50 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

ACPE: PIM designates this continuing education activity for 2.50 contact hour(s) (.25) of the Accreditation Council for Pharmacy Education. Universal Activity Number – JA4008162-9999-26-082-L01-P

2.5 AMA PRA Category 1 Credits™

2.5 AAPA

2.5 Contact Hours

TARGET AUDIENCE

PhysicianPharmacistPhysician AssistantCardiologistsGenetic counselorsInternistGastroenterologistsEndocrinologistClinical PharmacistsNurse PractitionersPrimary Care ProvidersCardiovascular Nurses